| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1089/104454902762053864 |
| P8608 | Fatcat ID | release_djanx2tpgvhhpeguhxgi6an2ta |
| P698 | PubMed publication ID | 12573050 |
| P2093 | author name string | Joseph C Glorioso | |
| Edward A Burton | |||
| David J Fink | |||
| P433 | issue | 12 | |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 915-936 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | DNA and Cell Biology | Q5205740 |
| P1476 | title | Gene delivery using herpes simplex virus vectors | |
| P478 | volume | 21 |
| Q34286445 | A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system |
| Q37397418 | A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency |
| Q45879506 | A realistic chance for gene therapy in the near future |
| Q41699782 | Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine |
| Q26770355 | Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain |
| Q39905853 | Bone morphogenetic proteins and tissue engineering: future directions |
| Q40025413 | Evaluation of the T-REx transcription switch for conditional expression and regulation of HSV-1 vectors |
| Q36532106 | Gene therapeutics: the future of brain tumor therapy? |
| Q39923388 | Herpes Virus Amplicon Vectors |
| Q36444443 | Herpes simplex virus 1 (HSV-1) for cancer treatment |
| Q44793632 | Human adipose tissue-derived mesenchymal stromal cells as vehicles for tumor bystander effect: a model based on bioluminescence imaging |
| Q37038838 | Imaging gene delivery with fluorescence microscopy |
| Q39592392 | Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen. |
| Q37204756 | Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice |
| Q34296144 | Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines |
| Q37153961 | Increased expression of 5-HT(1B) receptors by Herpes simplex virus gene transfer in septal neurons: New in vitro and in vivo models to study 5-HT(1B) receptor function |
| Q100455120 | Modulating gene regulation to treat genetic disorders |
| Q35200626 | Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy |
| Q39339386 | Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells |
| Q40436034 | Potential of equine herpesvirus 1 as a vector for immunization |
| Q35762295 | Preclinical safety testing of biotechnology-derived pharmaceuticals: understanding the issues and addressing the challenges |
| Q35577275 | Primer on Medical Genomics Part X: Gene Therapy |
| Q46804409 | Recombinant herpes vector-mediated analgesia in a primate model of hyperalgesia |
| Q36569912 | Regulatable gene expression systems for gene therapy |
| Q36157542 | Regulatable gene expression systems for gene therapy applications: progress and future challenges |
| Q38513773 | Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration |
| Q34267418 | Target discovery |
| Q37895283 | Targeting the central nervous system with herpes simplex virus / Sleeping Beauty hybrid amplicon vectors |
| Q41039041 | The virion host shutoff protein of herpes simplex virus type 1 has RNA degradation activity in primary neurons |
| Q35696375 | Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases |
| Q35903203 | Update on herpesvirus amplicon vectors |
| Q45880904 | Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors |
| Q36684458 | Viral gene therapy |
| Q36960666 | Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production. |
Search more.